Patents by Inventor Olivier Ballevre

Olivier Ballevre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150201656
    Abstract: Extruded food puffs comprising sweet potato have a density between 0.15 and 0.52 g/cm3. The sweet potato may be purple sweet potato. A composition comprising the extruded food puffs and a process for manufacturing extruded food puffs.
    Type: Application
    Filed: July 18, 2012
    Publication date: July 23, 2015
    Applicant: NESTEC S.A.
    Inventors: Chuling Claire Liang, Olivier Ballevre, Catherine Dionis, Yongcheng Liao
  • Patent number: 9072769
    Abstract: The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have anti-inflammatory properties. One embodiment of the present invention relates to the use of a primary composition comprising wolfberries or a part thereof for the preparation of a product to treat or prevent inflammation.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: July 7, 2015
    Assignees: Nestec S.A., L'Oreal
    Inventors: Karine Vidal, Stephanie Blum-Sperisen, David Philippe, Olivier Ballevre, Peter Bucheli, Junkuan Wang
  • Publication number: 20140308424
    Abstract: Disclosed is dried fruit or vegetable pulp preparation comprising dried fruit or vegetable pulp and at least one density modifying ingredient. The density modifying ingredient may be selected from the group consisting of complex carbohydrates or humectants.
    Type: Application
    Filed: July 22, 2011
    Publication date: October 16, 2014
    Applicant: NESTEC S.A.
    Inventors: Hua Bai, Yong-Cheng Liao, Zhong-wei Sun, Olivier Ballevre, Qingzhu Zhao
  • Patent number: 8383680
    Abstract: A method is provided for the prevention and treatment of patients having impaired gastro-intestinal tract function. The method comprises the steps of administering to a patient requiring same free amino acids including about 9.0% to about 17.0% glutamic acid.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: February 26, 2013
    Assignee: Nestec S.A.
    Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
  • Patent number: 8178487
    Abstract: A method of providing glutamine to a patient. A nutritional composition which includes whey protein, or a protein mixture which simulates the amino acid profile of whey protein, as a protein source is enterally administered to the patient. The whey protein may be a hydrolyzed whey protein. The patient may be a stressed patient, pre-term baby, or athlete.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: May 15, 2012
    Assignee: Nestec S.A.
    Inventors: Julio Boza, Olivier Ballevre, Paul-Andre Finot
  • Publication number: 20120035234
    Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.
    Type: Application
    Filed: October 18, 2011
    Publication date: February 9, 2012
    Applicant: Nestec S.A.
    Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-André Finot
  • Patent number: 8067471
    Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. Methods of treatment of impaired gastro-intestinal tract function are described.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: November 29, 2011
    Assignee: Nestec S.A.
    Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-André Finot
  • Publication number: 20110162981
    Abstract: Methods for using wolfberry for one or more of preventing, reducing, or treating damage caused by ischemia and ischemia-like conditions; preventing, reducing, or treating strokes and damage caused by strokes; preventing, reducing, or treating alterations in brain function; preventing, reducing, or treating cognitive dysfunction syndrome; preventing, reducing, or treating mild cognitive impairment; preventing, reducing, or treating dementia; preventing, reducing, or treating a decline in social interaction; preventing, reducing, or treating age-related behavioral changes; facilitating, maintaining, and enhancing cognitive function; facilitating, maintaining, and enhancing learning and memory; facilitating, maintaining, and enhancing optimal brain function; reducing memory loss; increasing trainability; improving the quality of life; and promoting the health and wellness in an animal.
    Type: Application
    Filed: July 30, 2009
    Publication date: July 7, 2011
    Inventors: Yuanlong Pan, Olivier Ballevre, Peter Bucheli
  • Publication number: 20100303741
    Abstract: The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have anti-inflammatory properties. One embodiment of the present invention relates to the use of a primary composition comprising wolfberries or a part thereof for the preparation of a product to treat or prevent inflammation.
    Type: Application
    Filed: September 12, 2008
    Publication date: December 2, 2010
    Applicant: NESTEC S.A.
    Inventors: Karine Vidal, Stephanie Blum-Sperisen, David Philippe, Olivier Ballevre, Peter Bucheli, Junkuan Wang
  • Patent number: 7794744
    Abstract: The present invention relates to a method for preparing an enteral nutrition at the bed of a patient, which involves the use of a standard enteral solution to which is added, via a closed system, one or more compositions in module form, containing selected nutrients, adapted for a specific clinical condition. The present invention also pertains to the different modules, that are preferably in dry form and to the use thereof in the treatment and/or nourishment of a critically ill person.
    Type: Grant
    Filed: April 3, 2001
    Date of Patent: September 14, 2010
    Assignee: Nestec S.A.
    Inventors: Olivier Ballevre, Julio Boza, Denis Breuille, Paul-André Finot, Véronique Jaussan, Claudia Roessle, Thomas Schweizer
  • Publication number: 20100221372
    Abstract: The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have anti-inflammatory properties. One embodiment of the present invention relates to the use of a primary composition comprising wolfberries or a part thereof for the preparation of a product to treat or prevent inflammation.
    Type: Application
    Filed: September 12, 2008
    Publication date: September 2, 2010
    Inventors: Karine Vidal, Stéphanie Blum-Sperisen, David Philippe, Olivier Ballevre, Peter Bucheli, Junkuan Wang
  • Patent number: 7776332
    Abstract: A composition for an infant formula which includes casein protein and whey protein; a method of producing the composition; use of the composition in the manufacture of a medicament or nutritional product for addressing malnutrition; and a method of addressing malnutrition which includes administering an effective amount of the composition are provided. The composition includes protein, free arginine; tryptophan and histidine, a lipid source and a carbohydrate source. In addition, the whey protein is sweet whey protein from which caseino-glyco-macropeptide has been removed.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: August 17, 2010
    Assignee: Nestec S.A.
    Inventors: Martinas Kuslys, Marie-Christine Secretin, Rolf Jost, Jean-Claude Maire, Olivier Ballevre, Ferdinand Haschke, Zdenek Kratky, Niklaus Meister
  • Patent number: 7666830
    Abstract: Protein hydrolyzates are used for prevention of bacterial overgrowth. In addition it was shown in sucklings mammals that specific protein hydrolyzates promote an intestinal flore pattern which is similar to the one of mammals raised by their mother. Other advantages are that the hydrolyzate is easier to obtain and simpler to administrate than treatment of bacterial overgrowth with the aid of active principles.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: February 23, 2010
    Assignee: Nestec S.A.
    Inventors: Clara L. Garcia-Rodenas, Olivier Ballevre, Florence Rochat
  • Publication number: 20090075862
    Abstract: A method of providing glutamine to a patient. A nutritional composition which includes whey protein, or a protein mixture which simulates the amino acid profile of whey protein, as a protein source is enterally administered to the patient. The whey protein may be a hydrolyzed whey protein. The patient may be a stressed patient, pre-term baby, or athlete.
    Type: Application
    Filed: November 24, 2008
    Publication date: March 19, 2009
    Applicant: NESTEC S.A.
    Inventors: Julio Boza, Olivier Ballevre, Paul-Andre Finot
  • Patent number: 7320810
    Abstract: The present invention relates to food products comprising in percent by weight of dry matter, 0.5-5% of a viscous soluble fibre, 2-20% oat bran concentrate, and 7-35% cereal bran. The specific amount of these constituents provide for a high viscosity and are suitable to delay glucose absorption or appearance in blood and/or to maintain raised glucose levels while avoiding high glucose peaks. The high viscosity of a food product was shown to be a key factor in the appearance of glucose in the blood stream. Hence, the food products according to the present invention are also suitable for diabetic patients.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: January 22, 2008
    Assignee: Nestec S.A.
    Inventors: Piere Wuersch, Olivier Ballevre, Hubert Milon, Birgit Sievert
  • Patent number: 7141554
    Abstract: A nutritional composition is disclosed which comprises synergistic functional carbohydrates for preventing or treating infection by pathogenic bacteria and/or promoting gut flora balance and health. The carbohydrates have a synergistic activity on promoting bifidobacteria in the intestine. Also disclosed are a method of production of the composition; and a method of treatment of infection by pathogenic bacteria and/or promoting gut flora balance and health which comprises administering an effective amount of the composition.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: November 28, 2006
    Assignee: Nestec S.A.
    Inventors: Florence Rochat, Olivier Ballevre, Alfred Jann
  • Publication number: 20060247312
    Abstract: A composition is described that can be used in prevention or treatment of patients having impaired gastro-intestinal tract function. The composition comprises free amino acids including about 9.0% to about 17.0% glutamic acid. A method of production of the composition; use of the composition in the manufacture of a medicament; and a method of treatment of impaired gastro-intestinal tract function are described.
    Type: Application
    Filed: April 28, 2006
    Publication date: November 2, 2006
    Applicant: NESTEC S.A.
    Inventors: Constance Whippie, Olivier Ballevre, Julio Boza, Paul-Andre Finot
  • Publication number: 20060171936
    Abstract: The present invention relates to the use of an effective amount of at least one microorganism belonging to the species Lactobacillus paracasei or casei, a fraction thereof or a metabolite thereof, in combination with an effective amount of at least one microorganism belonging to the species Bifidobacterium longum or Bifidobacterium lactis, a fraction thereof or a metabolite thereof, for producing a dermatological composition intended for treating and/or preventing reactive sensitive skin that may or may not be associated with dryness of the skin.
    Type: Application
    Filed: October 4, 2005
    Publication date: August 3, 2006
    Applicants: L'OREAL, NESTEC S.A.
    Inventors: Audrey Gueniche, Lionel Breton, Olivier Ballevre, Stephanie Blum-Sperisen, Isabelle Bureau-Franz, Jalil Benyacoub
  • Publication number: 20050153019
    Abstract: Compositions and methods that stimulate body protein synthesis and can improve muscle mass maintenance and recovery are provided. The composition comprises (i) a protein source which provides at least about 8% total calories of the composition and which includes at least about 50% by weight of whey protein; (ii) a lipid source having an omega 3:6 fatty acid ratio of about 5:1 to about 10:1 and which provides at least about 18% total calories of the composition; (iii) a carbohydrate source; and (iv) a balanced macronutrient profile comprising at least vitamin E and vitamin C.
    Type: Application
    Filed: March 9, 2005
    Publication date: July 14, 2005
    Inventors: Eileen Fuchs, Clara Garcia-Rodenas, Yves Guigoz, Peter Leathwood, Kristel Reiffers-Magnani, Chandrasekhara Mallangi, Marco Turini, Helen Anantharaman, Bernard Beaufrere, Martial Dangin, Olivier Ballevre
  • Publication number: 20050053641
    Abstract: A nutritional composition is disclosed which comprises synergistic functional carbohydrates for preventing or treating infection by pathogenic bacteria and/or promoting gut flora balance and health. The carbohydrates have a synergistic activity on promoting bifidobacteria in the intestine. Also disclosed are a method of production of the composition; and a method of treatment of infection by pathogenic bacteria and/or promoting gut flora balance and health which comprises administering an effective amount of the composition.
    Type: Application
    Filed: September 16, 2004
    Publication date: March 10, 2005
    Applicant: Nestec S.A., a Swiss corporation
    Inventors: Florence Rochat, Olivier Ballevre, Alfred Jann